Lobectomy

Surgical approach

  • Indications: lung cancer (most common), bronchiectasis, TB/fungal disease, benign tumours, trauma
  • Approaches
    • VATS/robotic lobectomy: 2–4 ports ± utility incision; less pain/LOS, but still major physiological insult
    • Open thoracotomy (posterolateral): rib spreading; more pain, higher respiratory compromise
  • Key surgical steps (typical)
    • Lateral decubitus; single-lung ventilation; collapse operative lung
    • Hilum dissection: pulmonary vein branch, pulmonary artery branches, lobar bronchus divided and stapled
    • Fissure completion (staplers), specimen retrieval
    • Mediastinal lymph node sampling/dissection (oncology cases)
    • Air leak test; haemostasis; intercostal drain(s) placed; lung reinflated
  • Intraoperative events that affect anaesthesia
    • Need for lung isolation/OLV; periods of hypoxia; CO2 insufflation occasionally in VATS
    • Major bleeding risk (pulmonary artery injury), arrhythmias with hilar manipulation
    • Bronchial stump leak/air leak; conversion VATS → thoracotomy

Anaesthetic management (headline)

  • Type of anaesthesia
    • General anaesthesia with lung isolation is standard
    • Regional techniques are adjuncts for analgesia (thoracic epidural, paravertebral, erector spinae plane, serratus anterior plane)
  • Airway
    • Double-lumen tube (DLT) most common; bronchial blocker alternative (difficult airway, tracheostomy, paediatrics, need to remain intubated post-op with single-lumen tube)
    • Fibreoptic bronchoscopy to confirm position after intubation and after lateral positioning
  • Duration
    • Typically 2–4 hours (longer if complex dissection, adhesions, pneumonectomy conversion, robotic set-up)
  • How painful?
    • Thoracotomy: very painful (rib spreading, intercostal nerve injury) → high risk of splinting/atelectasis
    • VATS: moderate–severe; still benefits from regional analgesia and multimodal regimen
  • Monitoring/lines (typical)
    • A-line (beat-to-beat BP, ABGs), large-bore IV access; consider CVC if poor access/vasoactive infusions/major bleeding risk
    • Temperature, urinary catheter for longer cases; consider cardiac output monitoring selectively

Preoperative assessment and optimisation

  • Goals: assess operability (cardiorespiratory reserve), predict post-op lung function, plan OLV strategy and analgesia, reduce PPCs
  • History/examination
    • Symptoms: dyspnoea, exercise tolerance (stairs/shuttle), cough/sputum, haemoptysis, wheeze, chest pain
    • Smoking history; COPD/asthma; OSA; previous thoracic surgery/radiotherapy (adhesions, difficult OLV)
    • Cardiac: IHD, HF, AF; pulmonary HTN; prior chemo (cardiotoxicity e.g., anthracyclines)
  • Investigations
    • Spirometry: FEV1, FVC; consider bronchodilator optimisation
    • DLCO (gas transfer): strong predictor of perioperative risk
    • ABG if severe disease/hypercapnia suspected; CXR/CT; ECG; echo if indicated
    • Cardiopulmonary exercise testing (CPET) if borderline: VO2peak and anaerobic threshold (AT)
  • Predicted postoperative function (ppo)
    • Estimate using segment counting or perfusion scan: ppo = preop value × (remaining functional segments/total functional segments)
    • Interpretation (typical thresholds used in practice): ppoFEV1 or ppoDLCO < 30% predicted = high risk; 30–40% = increased risk; > 40% generally acceptable with other factors considered
  • Functional risk markers (commonly used)
    • CPET: VO2peak < ~10 ml/kg/min or AT < ~11 ml/kg/min suggests high risk; VO2peak > ~15 ml/kg/min lower risk (interpret alongside clinical context)
    • Stair climb: poor performance suggests higher risk (rough guide only)
  • Optimisation
    • Smoking cessation (ideally ≥4 weeks), bronchodilators/inhaled steroids as indicated, treat infection, chest physio, prehabilitation
    • Anaemia correction, nutrition, glycaemic control; VTE risk assessment

Anaesthetic technique: induction, maintenance, and positioning

  • Induction
    • Standard IV induction; consider haemodynamic stability (thoracic epidural may reduce SVR); avoid excessive opioids if aiming for early extubation
    • Muscle relaxation to facilitate DLT placement and surgical exposure
  • Airway/lung isolation choices
    • Left DLT often preferred (more forgiving anatomy); right DLT if left main bronchus pathology/left pneumonectomy etc.
    • Bronchial blocker: useful with difficult airway, existing ETT, or need for post-op ventilation without DLT exchange; slower collapse, harder suctioning
  • Positioning (lateral decubitus)
    • Check DLT position after turning; protect pressure points; axillary roll; secure head/neck; ensure dependent arm perfusion
    • Ventilation-perfusion: dependent lung better perfused; aim to ventilate dependent lung during OLV
  • Maintenance
    • Volatile or TIVA acceptable; avoid high FiO2 for prolonged periods if possible (absorption atelectasis), but prioritise oxygenation
    • Neuromuscular monitoring; depth of anaesthesia monitoring may help with low-flow/OLV and haemodynamic stability

One-lung ventilation (OLV): physiology and management

  • Key physiology
    • Shunt increases as non-ventilated lung still perfused; HPV reduces shunt by diverting blood to ventilated lung
    • Factors that inhibit HPV: high volatile concentrations, alkalosis, high pulmonary artery pressures, vasodilators; hypoxia and hypercapnia augment HPV (within limits)
  • Ventilation strategy during OLV (typical)
    • Protective ventilation: tidal volume ~4–6 ml/kg predicted body weight, plateau pressure ideally < 25 cmH2O, driving pressure minimised
    • PEEP to dependent lung (often 5 cmH2O, titrate to oxygenation/compliance); avoid excessive PEEP that increases dead space or diverts perfusion
    • Permissive hypercapnia may be acceptable if haemodynamics and ICP allow; avoid severe acidosis
  • Managing hypoxaemia during OLV (stepwise)
    • 1) Increase FiO2 to 1.0; check circuit, haemodynamics, Hb, and SpO2 trace
    • 2) Confirm lung isolation and DLT/blocker position with fibreoptic bronchoscopy; suction secretions; ensure operative lung fully collapsed
    • 3) Optimise ventilation: recruitment manoeuvre to dependent lung then titrate PEEP; adjust VT/RR to avoid high pressures
    • 4) Apply CPAP (e.g., 1–5 cmH2O) to non-dependent lung if surgeon allows; or intermittent two-lung ventilation
    • 5) Consider differential lung ventilation, pulmonary vasodilator avoidance, treat bronchospasm, and discuss temporary surgical pause
  • Fluid strategy
    • Aim for euvolaemia; avoid liberal fluids (risk of post-resection pulmonary oedema/ARDS), but maintain perfusion and renal function
    • Use balanced crystalloid; blood products guided by losses/viscoelastic testing where available; consider vasopressors early rather than fluid loading

Analgesia (thoracotomy and VATS)

  • Principles
    • Effective analgesia reduces splinting, improves cough/physio, reduces PPCs and chronic post-thoracotomy pain
  • Regional options
    • Thoracic epidural (TEA): excellent dynamic analgesia; risks: hypotension, urinary retention, motor block, epidural haematoma/infection; caution with anticoagulation
    • Paravertebral block/catheter: comparable analgesia with less hypotension; risk: pneumothorax, vascular puncture, LA toxicity
    • Erector spinae plane (ESP) catheter: easier/safer plane block; variable efficacy; useful when TEA contraindicated
    • Serratus anterior plane/intercostal blocks: helpful for VATS port pain; shorter duration unless catheter used
  • Systemic multimodal
    • Paracetamol + NSAID (if renal function/bleeding risk acceptable) + opioid (PCA) as rescue; consider ketamine infusion (opioid-sparing), magnesium, lidocaine infusion (unit dependent)
    • Avoid excessive sedation; prioritise early mobilisation and effective cough

Postoperative care and complications

  • Immediate post-op priorities
    • Oxygenation/ventilation, analgesia, chest drain management, haemodynamic stability, temperature, nausea control
    • Plan destination: PACU with enhanced monitoring vs HDU/ICU depending on reserve, extent of resection, intra-op events
  • Respiratory complications
    • Atelectasis, pneumonia, bronchospasm, prolonged air leak, pneumothorax, respiratory failure
    • Post-resection pulmonary oedema/ARDS: uncommon but severe; associated with pneumonectomy > lobectomy, high fluids, high airway pressures, right-sided resections
  • Cardiovascular complications
    • Atrial fibrillation (common after thoracic surgery), myocardial ischaemia, hypotension (epidural/bleeding), pulmonary embolism
  • Surgical complications relevant to anaesthesia
    • Bleeding (pulmonary artery), bronchopleural fistula, chylothorax (thoracic duct injury), recurrent laryngeal nerve injury (hoarseness/aspiration risk)
  • Extubation considerations
    • Aim for extubation in theatre if: good gas exchange on two-lung ventilation, normothermia, haemodynamic stability, adequate analgesia, acceptable airway pressures, minimal bleeding
    • Consider post-op NIV/CPAP in selected patients (COPD/OSA) with careful monitoring and surgical agreement
You are asked to anaesthetise a patient for VATS right upper lobectomy. What are your key preoperative assessments and how do you decide if they are fit for lobectomy?

Structure: (1) confirm indication/extent, (2) quantify respiratory reserve, (3) assess cardiac risk, (4) optimise and plan.

  • Respiratory reserve
    • Spirometry (FEV1/FVC) and bronchodilator optimisation
    • DLCO (strong predictor of complications)
    • Calculate ppoFEV1 and ppoDLCO (segment counting/perfusion scan); identify high-risk if <30% predicted
    • CPET if borderline: VO2peak and AT; very low values suggest high risk and need for MDT discussion/ICU planning
  • Cardiac assessment
    • ECG, symptoms, functional capacity; echo if murmur/HF/pulmonary HTN suspected; manage AF/IHD per guidelines
  • Optimisation and planning
    • Smoking cessation, treat infection, physio/prehab; plan lung isolation, invasive monitoring, and regional analgesia; discuss HDU/ICU
Describe the physiological changes during one-lung ventilation and the role of hypoxic pulmonary vasoconstriction (HPV).

Focus on shunt, V/Q mismatch, and factors affecting HPV.

  • OLV increases shunt because the non-ventilated lung continues to receive blood flow
  • HPV diverts blood away from hypoxic (non-ventilated) alveoli to ventilated regions, reducing shunt and improving PaO2
  • HPV is influenced by
    • Inhibited by: high volatile concentrations, pulmonary vasodilators, alkalosis; worsened by high PVR states
    • Augmented by: hypoxia and mild hypercapnia (within physiological limits)
During OLV the saturation falls to 85%. Give a structured management plan.

A stepwise approach is expected; include equipment, tube position, ventilation, and surgical options.

  • Immediate actions
    • Increase FiO2 to 1.0; check BP/CO, Hb, depth of anaesthesia, circuit integrity
  • Confirm lung isolation
    • Fibreoptic bronchoscopy: confirm DLT/blocker position; suction both lumens; ensure operative lung is not partially ventilated
  • Optimise dependent lung ventilation
    • Recruitment manoeuvre then titrated PEEP; reduce VT if high pressures; adjust RR to maintain acceptable CO2
  • Reduce shunt from non-dependent lung
    • Apply CPAP 1–5 cmH2O to non-dependent lung if surgical field allows; otherwise intermittent two-lung ventilation
  • Escalation
    • Discuss with surgeon: pause, adjust retraction, consider clamping pulmonary artery temporarily (rare/selected), or convert approach; consider differential ventilation strategies
Compare a double-lumen tube with a bronchial blocker for lobectomy.

Examiners look for indications, advantages/disadvantages, and practicalities (FOB, suction, post-op ventilation).

  • Double-lumen tube (DLT)
    • Advantages: faster lung collapse, easier suctioning/CPAP to operative lung, stable separation, easier switch between OLV and two-lung ventilation
    • Disadvantages: larger, more traumatic; difficult airway challenges; malposition with turning; may need exchange to single-lumen for post-op ventilation
  • Bronchial blocker
    • Advantages: can be used through single-lumen ETT (difficult airway); avoids tube exchange if post-op ventilation anticipated
    • Disadvantages: slower collapse; suctioning limited; less effective CPAP; displacement risk; more FOB dependence
Outline an analgesic plan for thoracotomy lobectomy in a patient on anticoagulation where thoracic epidural is contraindicated.

Provide a safe regional alternative plus multimodal systemic analgesia and respiratory goals.

  • Regional alternatives
    • Paravertebral catheter if anticoagulation status allows per local/ASRA-style guidance; otherwise ESP catheter (more superficial plane) ± serratus/intercostal blocks
  • Systemic multimodal
    • Paracetamol ± NSAID (if appropriate), opioid PCA, consider ketamine infusion (opioid-sparing), antiemetics
  • Respiratory strategy
    • Avoid oversedation; encourage incentive spirometry, early mobilisation, physio; consider HDU monitoring
What are the major intraoperative complications of lobectomy and how would you manage them?

Think: bleeding, hypoxia, arrhythmias, air leak/BPF risk, and conversion to thoracotomy.

  • Major haemorrhage (pulmonary artery/vein injury)
    • Call for help, activate major haemorrhage protocol, rapid transfusion access, permissive hypotension only if agreed and short-lived, correct coagulopathy (TEG/ROTEM), communicate with surgeon (packing/clamping/conversion)
  • Hypoxaemia during OLV
    • Follow stepwise OLV hypoxia algorithm (FiO2, FOB, recruitment/PEEP, CPAP, intermittent two-lung ventilation)
  • Arrhythmias (especially AF) and haemodynamic instability
    • Treat reversible causes (hypoxia, pain, electrolytes); rate control (beta-blocker/amiodarone as appropriate), anticoagulation decisions post-op with surgical team
  • Air leak/bronchial injury
    • Avoid high airway pressures; coordinate reinflation tests; ensure adequate chest drainage; post-op ventilation strategy if significant leak/BPF suspected
A patient develops acute breathlessness and hypoxia in recovery after lobectomy. Give a differential diagnosis and immediate management.

A structured ABC approach with thoracic-specific causes scores well.

  • Immediate management
    • ABCDE, high-flow oxygen, sit up, assess airway patency, consider NIV if appropriate, obtain ABG
    • Check chest drains: swinging/bubbling, patency, suction settings; urgent CXR
  • Differential diagnosis
    • Atelectasis/mucus plugging, pneumonia, bronchospasm
    • Pneumothorax (including tension if drain blocked), haemothorax, persistent air leak
    • Pulmonary embolism, pulmonary oedema/ARDS, aspiration
    • Arrhythmia (AF) or myocardial ischaemia causing pulmonary oedema/hypoperfusion
Explain why thoracotomy is particularly painful and list consequences of inadequate analgesia.

Link anatomy to physiology and outcomes (PPCs, chronic pain).

  • Mechanisms of pain
    • Rib spreading → intercostal nerve injury; pleural irritation; chest drains; muscle division
  • Consequences of inadequate analgesia
    • Splinting → reduced FRC, atelectasis, pneumonia; ineffective cough → secretion retention
    • Sympathetic activation → tachycardia/ischaemia; delayed mobilisation; increased chronic post-thoracotomy pain risk
Discuss fluid management for lobectomy and why excessive fluid is harmful.

Examiners want a rationale: reduced lung tissue, capillary leak, and right heart strain.

  • Strategy
    • Aim euvolaemia; avoid liberal maintenance; replace measured losses; use vasopressors for vasodilation rather than repeated boluses
  • Why excessive fluid is harmful
    • Reduced pulmonary vascular bed post-resection + inflammatory permeability → pulmonary oedema/ARDS risk; worsens gas exchange and prolongs ventilation

0 comments